IMBRUVICA (Pharmacyclics LLC)
Welcome to the PulseAid listing for the IMBRUVICA drug offered from Pharmacyclics LLC. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pharmacyclics LLC |
| NON-PROPRIETARY NAME: | Ibrutinib |
| SUBSTANCE NAME: | IBRUTINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-11-13 |
| END MARKETING DATE: | 0000-00-00 |
IMBRUVICA HUMAN PRESCRIPTION DRUG Details:
| Item Description | IMBRUVICA from Pharmacyclics LLC |
| LABELER NAME: | Pharmacyclics LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 140(mg/1) |
| START MARKETING DATE: | 2013-11-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57962-140_23dd7dc3-2ef1-40b5-90b5-94244d781a54 |
| PRODUCT NDC: | 57962-140 |
| APPLICATION NUMBER: | NDA205552 |
Other IBRUTINIB Pharmaceutical Manufacturers / Labelers:
